Development of met DNA vaccine for gene therapy
碩士 === 國立成功大學 === 生物化學研究所 === 93 === Abstract C-met proto-oncogene is a receptor tyrosine kinase that mediates the oncogenic activities of the hepatocyte growth factor (HGF) which is a pleiotropic growth factor involved in a variety of cellular responses, such as proliferation, migration, survival...
Main Authors: | Ming-Chuan Chen, 陳明傳 |
---|---|
Other Authors: | Ming-Derg Lai |
Format: | Others |
Language: | zh-TW |
Published: |
2005
|
Online Access: | http://ndltd.ncl.edu.tw/handle/70224451842043725632 |
Similar Items
-
Development of DNA vaccines: Cytoplasmic ErbB-2/neu for Bladder Cancer Gene Therapy
by: Tai-Ming ko, et al.
Published: (2003) -
Improving gene delivery for gene therapy and DNA vaccination applications
by: Shaw, Paul Andrew
Published: (2006) -
Reviving the role of MET in liver cancer therapy and vaccination: an autophagic perspective
by: Xing Huang, et al.
Published: (2020-01-01) -
Development of HER-2/neu DNA Vaccine for Cancer Therapy
by: Chi-Chen Lin, et al.
Published: (2006) -
Application of Response Surface Method on Optimization Of Squid Surimi-based Product
by: Ming Chuan –Chen, et al.
Published: (2011)